Primary CNS lymphoma: can we use MATRix immunochemo in the real world?
Christopher Fox • 16 Apr 2018
Clinical trials, pathologies and developments in personalized medicine
Francesco d'Amore et al.
Exciting advances in checkpoint inhibitors, CAR T-cells and ALK inhibitors
Steven Rosen • 8 Sep 2017